Birchtech Corp. (BCHT), formerly Midwest Energy Emissions Corp. and renamed in October 2024, provides specialty activated-carbon technologies for air and water purification, including its Sorbent Enhancement Additive (SEA) mercury-capture technology for coal-fired power plants and an emerging water-treatment business focused on PFAS and PFOS (per- and polyfluoroalkyl substances).
Coverage of BCHT is exceptionally thin. Public data aggregators, including Yahoo Finance and Investing.com drawing on S&P Global data, list a single covering analyst with a 12-month price target of $15.00 and a "Buy" (strong-buy) rating. Because there is only one verifiable target, there is no meaningful analyst consensus, no reliable low-to-high range, and no basis to calculate a multi-analyst average price target. Some older third-party pages have shown lower figures, underscoring how unstable and data-limited this single estimate is. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For this reason, the $15 figure is best understood as a publicly available price objective from an extremely small sample, not as a forecast supported by broad institutional research. It should be read as a speculative, far-dated marker rather than a near-term expectation.
BCHT recently traded around $1.15, well below its 52-week high of $4.80 set in December 2025 and near its 52-week low of $1.01. Reaching $15 would require an increase of roughly 1,200%, a move that is extraordinarily large by any standard and far beyond what would be described as merely "substantial."
The company generates negative earnings, carries a negative P/E (price-to-earnings) ratio, and reported an estimated loss per share in its most recent quarter. A move toward $15 would therefore require a fundamental transformation, not a cyclical recovery — sustained revenue growth, a clear path to profitability, and a dramatic re-rating of a business whose entire market value is currently under $30 million. In June 2026, BCHT was added to the Russell 3000E Index, a step that can modestly improve visibility and passive ownership but does not by itself justify the target.
The most durable levels are wide apart. Near-term support sits around $1.01, the 52-week low, with the round $1.00 level serving as a psychological floor. On the upside, the stock would first need to reclaim its $4.80 prior high, a level that already sits more than four times above the current price. The $15 target lies far above any recent trading range, meaning there is no meaningful technical structure to anchor a path toward it in the near term. From what I see in the charts, this gap highlights just how far any sustained rally would need to travel.
Analyst price targets are typically framed over a roughly 12-month horizon, but with only one covering analyst and no documented horizon, that assumption cannot be relied upon here. Investors should monitor quarterly revenue trends, cash position, and gross-margin progress; any commercialization or licensing news in the PFAS/PFOS water business; mercury-capture contract activity; and regulatory developments around MATS and drinking-water standards. Share-count changes and any new financing are also critical for a micro-cap of this size. I’m watching this closely through tools that flag momentum shifts in low-liquidity names like this one.
Can BCHT reach $15? The question rests on a single analyst's price objective rather than a broad consensus, and the required move — roughly 1,200% from a price near $1.15 — is enormous for a company with negative earnings and a market value under $30 million. The mercury-capture franchise and PFAS/PFOS water opportunity provide genuine long-term optionality, but the path to $15 would demand transformational revenue growth, a durable return to profitability, and a complete re-rating. The principal obstacles are the shrinking coal market, execution risk in an unproven water business, and potential dilution. With only one verifiable target, no meaningful consensus, and no technical structure nearby, the $15 figure is best treated as a speculative, far-dated aspiration rather than a near-term forecast. Investors should watch revenue trends, cash use, and regulatory milestones closely before drawing any conclusions.
In my view, Tickeron's AI Daily Buy/Sell Signals have become a practical addition to my routine when looking at thinly covered names. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. For something like BCHT, where traditional coverage is sparse, it helps surface potential momentum changes without requiring constant manual monitoring.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BCHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 40 of 45 cases where BCHT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BCHT's RSI Oscillator exited the oversold zone, 35 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 59 cases where BCHT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on BCHT as a result. In 70 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for BCHT just turned positive on November 09, 2026. Looking at past instances where BCHT's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.
Following a +7.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCHT advanced for three days, in 143 of 191 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
BCHT moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BCHT crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BCHT entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.711) is normal, around the industry mean (10.189). P/E Ratio (-6.765) is within average values for comparable stocks, (-16.372). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.975). Dividend Yield (0.000) settles around the average of (0.050) among similar stocks. P/S Ratio (1.812) is also within normal values, averaging (251.106).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. BCHT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCHT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialSpecialties